Walleye Trading’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Walleye Trading’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,600	Closed	-$11	–	5178
2017 Q1	$11	Sell	3,600 -300	-8%	-$885	﹤0.01%	4321
2016 Q4	$11K	Buy	+3,900	New	+$11.2K	﹤0.01%	4295
2016 Q3	–	Sell	-5,100	Closed	-$26K	–	5680
2016 Q2	$26K	Buy	+5,100	New	+$24.5K	﹤0.01%	4408
2016 Q1	–	Sell	-700	Closed	-$6K	–	6050
2015 Q4	$6K	Buy	+700	New	+$5.84K	﹤0.01%	4900
2015 Q3	–	Sell	-700	Closed	-$7K	–	5726
2015 Q2	$7K	Buy	+700	New	+$6.52K	﹤0.01%	4428

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Walleye Trading's CORV Position: Q2 2017 in Review

Walleye Trading sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2017, closing a stake of 3,600 shares — an estimated $11 sold.

Walleye Trading first reported a position in CORV in Q2 2015 and held it in 5 quarters. The position peaked at $26K in Q2 2016. 27 funds tracked by Wall St. Rank hold CORV as of Q2 2017.

Walleye Trading reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2017 after selling out during the quarter.
Walleye Trading sold 3,600 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2017, an estimated $11.
Walleye Trading first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2015 and held it in 5 quarters.
Walleye Trading's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $26K in Q2 2016.
27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.